| pubmed-article:18061146 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18061146 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
| pubmed-article:18061146 | lifeskim:mentions | umls-concept:C0242485 | lld:lifeskim |
| pubmed-article:18061146 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:18061146 | lifeskim:mentions | umls-concept:C0520676 | lld:lifeskim |
| pubmed-article:18061146 | lifeskim:mentions | umls-concept:C0220839 | lld:lifeskim |
| pubmed-article:18061146 | lifeskim:mentions | umls-concept:C0024487 | lld:lifeskim |
| pubmed-article:18061146 | lifeskim:mentions | umls-concept:C0260061 | lld:lifeskim |
| pubmed-article:18061146 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:18061146 | pubmed:dateCreated | 2008-6-2 | lld:pubmed |
| pubmed-article:18061146 | pubmed:abstractText | Women who suffer from premenstrual dysphoric disorder (PMDD) classically display depressive and anxiety symptoms in the premenstrum. Preclinical and clinical studies have suggested a role of glutamate in anxiety and depression. This investigation aims at demonstrating fluctuations of glutamate across the menstrual cycle in the medial prefrontal cortex of women who suffer from PMDD and healthy control subjects (HCs). | lld:pubmed |
| pubmed-article:18061146 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18061146 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18061146 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18061146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18061146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18061146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18061146 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18061146 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:18061146 | pubmed:issn | 1873-2402 | lld:pubmed |
| pubmed-article:18061146 | pubmed:author | pubmed-author:BellavanceFra... | lld:pubmed |
| pubmed-article:18061146 | pubmed:author | pubmed-author:BakerGlenG | lld:pubmed |
| pubmed-article:18061146 | pubmed:author | pubmed-author:AllenPeterP | lld:pubmed |
| pubmed-article:18061146 | pubmed:author | pubmed-author:TibboPhilipP | lld:pubmed |
| pubmed-article:18061146 | pubmed:author | pubmed-author:KhudabuxJanis... | lld:pubmed |
| pubmed-article:18061146 | pubmed:author | pubmed-author:SeresPeterP | lld:pubmed |
| pubmed-article:18061146 | pubmed:author | pubmed-author:HanstockChris... | lld:pubmed |
| pubmed-article:18061146 | pubmed:author | pubmed-author:Le... | lld:pubmed |
| pubmed-article:18061146 | pubmed:author | pubmed-author:BatraNeha... | lld:pubmed |
| pubmed-article:18061146 | pubmed:author | pubmed-author:Seres-MailoJa... | lld:pubmed |
| pubmed-article:18061146 | pubmed:author | pubmed-author:HuiEricE | lld:pubmed |
| pubmed-article:18061146 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18061146 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:18061146 | pubmed:volume | 63 | lld:pubmed |
| pubmed-article:18061146 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18061146 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18061146 | pubmed:pagination | 1178-84 | lld:pubmed |
| pubmed-article:18061146 | pubmed:meshHeading | pubmed-meshheading:18061146... | lld:pubmed |
| pubmed-article:18061146 | pubmed:meshHeading | pubmed-meshheading:18061146... | lld:pubmed |
| pubmed-article:18061146 | pubmed:meshHeading | pubmed-meshheading:18061146... | lld:pubmed |
| pubmed-article:18061146 | pubmed:meshHeading | pubmed-meshheading:18061146... | lld:pubmed |
| pubmed-article:18061146 | pubmed:meshHeading | pubmed-meshheading:18061146... | lld:pubmed |
| pubmed-article:18061146 | pubmed:meshHeading | pubmed-meshheading:18061146... | lld:pubmed |
| pubmed-article:18061146 | pubmed:meshHeading | pubmed-meshheading:18061146... | lld:pubmed |
| pubmed-article:18061146 | pubmed:meshHeading | pubmed-meshheading:18061146... | lld:pubmed |
| pubmed-article:18061146 | pubmed:meshHeading | pubmed-meshheading:18061146... | lld:pubmed |
| pubmed-article:18061146 | pubmed:meshHeading | pubmed-meshheading:18061146... | lld:pubmed |
| pubmed-article:18061146 | pubmed:meshHeading | pubmed-meshheading:18061146... | lld:pubmed |
| pubmed-article:18061146 | pubmed:meshHeading | pubmed-meshheading:18061146... | lld:pubmed |
| pubmed-article:18061146 | pubmed:meshHeading | pubmed-meshheading:18061146... | lld:pubmed |
| pubmed-article:18061146 | pubmed:meshHeading | pubmed-meshheading:18061146... | lld:pubmed |
| pubmed-article:18061146 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18061146 | pubmed:articleTitle | Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder. | lld:pubmed |
| pubmed-article:18061146 | pubmed:affiliation | Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada. nbatra@ualberta.ca | lld:pubmed |
| pubmed-article:18061146 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18061146 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18061146 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18061146 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18061146 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18061146 | lld:pubmed |
